ATE470701T1 - Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe - Google Patents

Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe

Info

Publication number
ATE470701T1
ATE470701T1 AT06751317T AT06751317T ATE470701T1 AT E470701 T1 ATE470701 T1 AT E470701T1 AT 06751317 T AT06751317 T AT 06751317T AT 06751317 T AT06751317 T AT 06751317T AT E470701 T1 ATE470701 T1 AT E470701T1
Authority
AT
Austria
Prior art keywords
genidentic
cells
organs
tissues
materials
Prior art date
Application number
AT06751317T
Other languages
English (en)
Inventor
Elazer Edelman
Helen Nugent
Heiko Methe
Original Assignee
Massachusetts Inst Technology
Pervasis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Pervasis Therapeutics Inc filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE470701T1 publication Critical patent/ATE470701T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
AT06751317T 2005-04-21 2006-04-21 Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe ATE470701T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67341705P 2005-04-21 2005-04-21
US68221705P 2005-05-18 2005-05-18
PCT/US2006/015555 WO2006116357A1 (en) 2005-04-21 2006-04-21 Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs

Publications (1)

Publication Number Publication Date
ATE470701T1 true ATE470701T1 (de) 2010-06-15

Family

ID=36695000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06751317T ATE470701T1 (de) 2005-04-21 2006-04-21 Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe

Country Status (11)

Country Link
US (3) US20090087414A1 (de)
EP (1) EP1874919B1 (de)
JP (2) JP5174656B2 (de)
CN (1) CN101268183B (de)
AT (1) ATE470701T1 (de)
AU (1) AU2006238892B2 (de)
CA (1) CA2605080A1 (de)
DE (1) DE602006014814D1 (de)
ES (1) ES2347078T3 (de)
HK (1) HK1116829A1 (de)
WO (1) WO2006116357A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795480B2 (en) 2010-08-24 2017-10-24 Millipede, Inc. Reconfiguring tissue features of a heart annulus

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE470701T1 (de) 2005-04-21 2010-06-15 Massachusetts Inst Technology Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe
CN101878757A (zh) 2005-06-21 2010-11-10 渗透治疗有限公司 用于增强血管通路的方法和组合物
CN103230414A (zh) * 2006-11-07 2013-08-07 夏尔再生医学公司 用于治疗和控制血管生成介导的疾病的材料和方法
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
WO2008121331A1 (en) * 2007-03-30 2008-10-09 Pervasis Therapeutics, Inc. Materials and methods for treating nerve damage and promoting nerve repair and regeneration
WO2009020650A2 (en) * 2007-08-08 2009-02-12 Pervasis Therapeutics, Inc. Materials and methods for treating and managing wounds and the effects of trauma
EP2535063A1 (de) * 2007-08-08 2012-12-19 Pervasis Therapeutics, Inc. Materialien und Verfahren zur Behandlung von Schäden des Skelettsystems und zur Förderung der Reparatur und Regeneration des Skelettsystems
EP2376115A4 (de) 2008-12-11 2013-07-03 Univ Alberta Verfahren und system zur induzierung von immunologischer toleranz bei fremdantigenen
EP2826494B1 (de) * 2012-03-12 2021-01-06 Fujifilm Corporation Verfahren zur herstellung von gewebereparaturmaterial
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
US20160121023A1 (en) * 2014-10-30 2016-05-05 Massachusetts Institute Of Technology Materials and Methods for Rescue of Ischemic Tissue and Regeneration of Tissue Integrity During Resection, Engraftment and Transplantation
CN107530166B (zh) 2015-02-13 2020-01-31 魅尔皮德股份有限公司 使用旋转锚固件的瓣膜置换
AU2016314768A1 (en) * 2015-08-28 2018-03-22 Ctm@Crc Ltd. Products and methods for activating and/or expanding T cells
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
US10555813B2 (en) 2015-11-17 2020-02-11 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
WO2018148584A1 (en) 2017-02-10 2018-08-16 Millipede, Inc. Implantable device and delivery system for reshaping a heart valve annulus
JP6906760B2 (ja) * 2017-03-28 2021-07-21 国立大学法人京都工芸繊維大学 持効性／徐放性骨破壊阻止剤
WO2020112904A1 (en) * 2018-11-26 2020-06-04 Massachusetts Institute Of Technology Compositions and methods for immune tolerance
CN112546665B (zh) * 2020-12-01 2022-03-01 晨光生物科技集团股份有限公司 一种去除花椒中塑化剂的方法及花椒油树脂的制备方法和花椒油树脂

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US614039A (en) * 1898-11-08 turney
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
IL78950A (en) 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US6309635B1 (en) * 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US4945086A (en) 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
CH676195A5 (de) * 1988-10-07 1990-12-28 Sulzer Ag
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
WO1991007154A1 (en) * 1989-11-13 1991-05-30 President And Fellows Of Harvard College EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
ATE237682T1 (de) 1991-07-15 2003-05-15 Oklahoma Med Res Found Universale spenderzellen
US5336615A (en) 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB9306449D0 (en) 1993-03-29 1993-05-19 Nat Heart Research Fund Tissue equivalents
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5645829A (en) * 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
AU2399495A (en) 1994-04-29 1995-11-29 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
WO1996011671A1 (en) * 1994-10-12 1996-04-25 Focal, Inc. Targeted delivery via biodegradable polymers
US6911216B1 (en) * 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
AU766693B2 (en) * 1998-11-24 2003-10-23 Emory University Transgenic circulating endothelial cells
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6387116B1 (en) * 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
AU2001243248A1 (en) 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
US6676971B2 (en) * 2000-03-13 2004-01-13 Biocure, Inc. Embolic compositions
EP1263484B1 (de) * 2000-03-15 2007-05-16 OrbusNeich Medical, Inc. Beschichtung welche ein anhaften von endothelzellen stimuliert
US6506398B1 (en) * 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
EP1301197A2 (de) 2000-07-21 2003-04-16 The Board Of Regents, The University Of Texas System Apparat mit regulierter freisetzung von wachstums zur regeneration peripherer nerven
US6696483B2 (en) * 2000-10-03 2004-02-24 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
US6565601B2 (en) * 2000-11-15 2003-05-20 Micro Therapeutics, Inc. Methods for vascular reconstruction of diseased arteries
EP1389078A4 (de) 2000-12-27 2004-03-17 Ortec International Inc Verfahren zur herstellung kryokonservierter zusammengesetzter lebendkonstrukte und daraus gebildete produkte
DE60237671D1 (de) * 2001-01-16 2010-10-28 Vascular Therapies Llc Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate
US6723131B2 (en) * 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
WO2003026489A2 (en) 2001-09-28 2003-04-03 University Of Florida Biopolymer and biopolymer-cell compositions for nerve tissue repair
AU2002363322A1 (en) * 2001-10-26 2003-05-19 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
WO2003060138A1 (en) * 2001-12-21 2003-07-24 The United States Of America Represented By The Secretary Of The U.S. Department Of The Navy In increasing gene transfer efficiency by pre-incubation with endothelial cells
US7297540B2 (en) 2002-01-15 2007-11-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
WO2003083044A2 (en) 2002-03-25 2003-10-09 Condros, Inc. Tissue analogs for in vitro testing and method of use therefor
US20050008629A1 (en) * 2002-05-08 2005-01-13 Interpore Orthopaedics, A Delaware Corporation Encapsulated AGF cells
CA2490811A1 (en) 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
GB0322789D0 (en) 2003-09-30 2003-10-29 Lifeforce Group Plc Blood pack for leukocyte banking
WO2005052138A1 (en) * 2003-11-19 2005-06-09 Wisconsin Alumni Research Foundation Cryopreservation of pluripotent stem cells
US8067368B2 (en) 2004-01-27 2011-11-29 The Ohio State University Research Foundation Vascular endothelial growth factors and methods of their use
US7670596B2 (en) 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
FR2869533B1 (fr) 2004-05-03 2006-07-28 Sedat Sa Seringue pour interventions medicales et necessaire de reconstitution de substances extemporanees comportant une telle seringue
US7842304B2 (en) 2004-10-29 2010-11-30 Nexeon Medsystems, Inc. Methods and apparatus for treating an injured nerve pathway
WO2006062909A2 (en) 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
EP1824417A2 (de) 2004-12-08 2007-08-29 Pervasis Therapeutics, Inc. Materialien und verfahren für behandlung und management von plaque
WO2006062871A2 (en) 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Materials and methods for minimally-invasive administration of a cell-containing flowable composition
ATE470701T1 (de) 2005-04-21 2010-06-15 Massachusetts Inst Technology Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe
GB0509845D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Preparation of therapeutic foam
CN101878757A (zh) 2005-06-21 2010-11-10 渗透治疗有限公司 用于增强血管通路的方法和组合物
JP5015160B2 (ja) 2005-10-12 2012-08-29 セルラー・バイオエンジニアリング・インコーポレイテッド 再吸収可能な角膜ボタン（ｒｅｓｏｒｂａｂｌｅｃｏｒｎｅａｂｕｔｔｏｎ）
WO2007053799A2 (en) * 2005-10-19 2007-05-10 Cd Solutions, Llc Apparatus and method for mixing and transferring medications
CN101437463B (zh) * 2005-11-07 2012-12-05 伯尔拉工业有限公司 通气的安全处理小瓶配接器

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795480B2 (en) 2010-08-24 2017-10-24 Millipede, Inc. Reconfiguring tissue features of a heart annulus

Also Published As

Publication number Publication date
AU2006238892B2 (en) 2011-01-27
CN101268183A (zh) 2008-09-17
US20090087414A1 (en) 2009-04-02
US20130177600A1 (en) 2013-07-11
WO2006116357A1 (en) 2006-11-02
JP5174656B2 (ja) 2013-04-03
US20120308610A1 (en) 2012-12-06
CN101268183B (zh) 2011-11-30
CA2605080A1 (en) 2006-11-02
ES2347078T3 (es) 2010-10-25
EP1874919B1 (de) 2010-06-09
JP2012224644A (ja) 2012-11-15
HK1116829A1 (en) 2009-01-02
EP1874919A1 (de) 2008-01-09
DE602006014814D1 (de) 2010-07-22
JP2008538587A (ja) 2008-10-30
US9040092B2 (en) 2015-05-26
AU2006238892A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
ATE470701T1 (de) Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene,einschliesslich genidentischer und nicht- genidentischer zellen, gewebe oder organe
Birla et al. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue
US10959833B2 (en) Implantable prosthesis having acellular tissue attachments
ES2706401T3 (es) Estructura saquiforme con actividad paracrina y métodos para su preparación
Machingal et al. A tissue-engineered muscle repair construct for functional restoration of an irrecoverable muscle injury in a murine model
Kirsner The use of Apligraf in acute wounds
Iyyanki et al. Adipose-derived stem-cell-seeded non-cross-linked porcine acellular dermal matrix increases cellular infiltration, vascular infiltration, and mechanical strength of ventral hernia repairs
WO2012002986A3 (en) Decellularized and delipidized extracellular matrix and methods of use
WO2012009377A3 (en) Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
WO2017185853A1 (zh) 一种复合细胞外基质成分生物材料
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
Lin et al. Cavernous nerve repair with allogenic adipose matrix and autologous adipose-derived stem cells
RU2012104650A (ru) Кондиционированная среда и композиции на основе внеклеточного матрикса из клеток, культивированных в гипоксических условиях
EP2150612A4 (de) Hybrid-weichteilimplantate aus vorläuferzellen und biomaterialien
ES2943332T3 (es) Producto sanitario de ingeniería tisular
ES2761307T3 (es) Proceso para la producción de parches o apósitos de piel autóloga mediante cultivo de queratinocitos y fibroblastos autólogos con suero autólogo para generación de piel
Katerinaki et al. Histological appearance of Stratticetm tissue matrix used in breast reconstruction
RU2017125478A (ru) Биосовместимые имплантаты, содержащие сконструированные эндотелиальные клетки
BR112017001550B1 (pt) método de produção de um enxerto de tecido e enxerto de pele dermoepidérmico
BR112016009178B1 (pt) Método de preparação de um produto de tecido e uso de um produto de tecido
Mestak et al. Mesenchymal Stem Cells Seeded on Cross‐Linked and Noncross‐Linked Acellular Porcine Dermal Scaffolds for Long‐Term Full‐Thickness Hernia Repair in a Small Animal Model
Wu et al. Tissue engineering in female pelvic floor reconstruction
KR20010072553A (ko) 살아있는 키메릭 피부 대체물
Hafizah et al. Properties of cell sources in tissue-engineered three-dimensional oral mucosa model: A review
CN100496623C (zh) 异种脱蛋白骨支架材料及其制备方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties